Compounds and methods for treating dyslipidemia

Disclosed is a compound of Formula I wherein Y is a bond, C=O, or S(O)t; and wherein the rest of the substituents are disclosed within the specification; or a pharmaceutically acceptable salt, enantiomer, racemate, diastereomer or mixture of diastereomers thereof. Also disclosed is the use of a comp...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MATEO-HERRANZ, ANA ISABEL, WANG, XIAODONG, CIOFFI, CHRISTOPHER LAWRENCE, DE LA NAVA, EVA MARIA MARTIN, CHEN, XINCHAO, DINN, SEAN RICHARD, FERNANDEZ, MARIA CARMEN, HERR, ROBERT JASON, ESCRIBANO, ANA MARIA, PARTHASARATHY, SARAVANAN, FIELDS, TODD, MANTLO, NATHAN BRYAN
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Disclosed is a compound of Formula I wherein Y is a bond, C=O, or S(O)t; and wherein the rest of the substituents are disclosed within the specification; or a pharmaceutically acceptable salt, enantiomer, racemate, diastereomer or mixture of diastereomers thereof. Also disclosed is the use of a compound of Formula I for the manufacture of a medicament for modulating CETP activity in a mammal.